There is no evidence that AI misdiagnosis is bankrupting hospitals. The large financial estimates in current research concern diagnostic errors across healthcare generally, not errors caused by AI. Clinical AI can still influence diagnostic decisions, and poorly performing or biased systems can increase risk. Hospitals therefore need to validate these tools in their intended workflows and monitor them after deployment—while keeping AI-specific costs separate from broader diagnostic-error estimates.
What do the financial estimates actually measure?
Diagnostic errors can lead to additional care, patient harm, and malpractice claims. But published estimates differ in what they count, which period they cover, and how errors are identified. They are not interchangeable, and neither establishes AI-related losses.
As an Amazon Associate I earn from qualifying purchases.
| Estimate | What it measures | How to interpret it |
|---|---|---|
| $5.7 billion over 12 years | An Agency for Healthcare Research and Quality (AHRQ) issue brief’s estimate of costs associated with inpatient diagnostic errors generally. | Not an annual current total and not attributable to AI. AHRQ describes the evidence base for estimating the burden as limited. |
| $5.7 billion over the study period | Inpatient diagnosis-related malpractice payments in a 2017 study by A. S. Saber Tehrani and colleagues, as reported in its PubMed record. | Paid claims are not all costs of diagnostic errors, all hospital expenses, or an AI-specific figure. |
| $100 billion annually in the United States | An OECD 2025 discussion of a cited estimate of diagnostic-error costs that includes malpractice litigation costs. | The OECD notes that estimates depend on definitions, care settings, and detection and reporting methods. It is not an audited total or an AI-related estimate. |
These figures use different methods and periods. Adding them would double-count or combine unlike measures, and none shows that AI-driven errors are pushing hospitals toward insolvency. AHRQ says diagnostic errors contribute to about 10% of patient deaths and are a primary reason for medical liability claims; that statement concerns diagnostic errors generally, not AI-caused errors.
Recommended Free Tools
How common are diagnostic errors in hospitals?
AHRQ’s 2025 final report on the UPSIDE project found diagnostic errors in 550 of 2,428 reviewed patient records, or 23.0% (95% confidence interval 20.9–25.3%). The records came from 29 hospitals and were selected because the patients died in hospital or transferred to an intensive care unit. This is a high-risk cohort, not a prevalence estimate for all hospitalized patients.
In 436 of those 2,428 records, or 17.8%, reviewers judged that diagnostic error contributed to temporary harm, permanent harm, or death. That finding likewise applies to the selected cohort. It does not identify AI as the cause.
Can AI make diagnostic errors worse?
Yes, in some circumstances—but the available evidence does not establish that deployed AI is increasing hospital misdiagnosis rates. A randomized clinical vignette study summarized by AHRQ PSNet in 2024 tested hospital clinicians on acute respiratory failure cases involving pneumonia, heart failure, or COPD. Clinician diagnostic accuracy was 73% at baseline. AI suggestions improved accuracy overall in the study, but systematically biased suggestions had a larger adverse effect on accuracy.
Rank #2
The result illustrates a risk sometimes called automation bias: a clinician may be influenced by an AI suggestion even when it is wrong. Because this was a vignette experiment, it does not measure patient outcomes or prove that real-world hospital AI deployments cause more errors. It does show why performance and workflow matter: a tool can help on average while still making decisions worse when its predictions are biased.
What do AI device safety reports show?
Reports of device safety events can surface concerns, but they do not provide a complete count of incidents or a risk rate. FDA’s MAUDE database is a voluntary reporting system; reports may be incomplete or unevenly submitted, and a report alone does not prove that a device caused harm.
- A 2024 study summarized by AHRQ PSNet in 2025 identified 429 safety reports associated with AI/ML-enabled devices; about one-quarter were potentially related to AI/ML. This is a count of reports, not an incidence rate.
- An earlier analysis by Lyell and colleagues, summarized by AHRQ PSNet, found mammography implicated in 69% of the reports in that analysis, and most described events were near misses. Those percentages describe that reported-event dataset, not the risk across all AI devices or deployments.
These findings can help identify issues that warrant investigation, but they cannot establish how often AI causes diagnostic errors or what those errors cost hospitals.
How should hospitals manage AI diagnostic risk?
FDA research on postmarket monitoring notes that data acquisition systems, protocols, and patient populations can change. A model’s performance may vary when inputs differ from those it was evaluated on. Monitoring should therefore continue after deployment; a one-time evaluation is not enough to detect every change.
Rank #4
Before deployment
- Define the intended use and workflow. Specify which decisions the tool informs, which patients it is intended for, and how clinicians are expected to use its output.
- Check validation fit. Compare the evaluation population and clinical sites with the hospital’s own patients and settings. Evidence from one site or population may not establish performance elsewhere.
- Plan for unfamiliar inputs. Determine how the system handles data outside the range it was evaluated on and what clinicians should do when an output is uncertain or unsuitable.
- Make outputs reviewable. Establish how staff can inspect, question, and document AI suggestions rather than treating them as unchallengeable answers.
After deployment
- Monitor inputs and outputs. Track changes in incoming data and model performance to help identify drift or variation.
- Audit across sites and patient groups. Look for performance differences that could be hidden by an overall average, including changes in local protocols or patient populations.
- Set a response process. Assign responsibility for investigating performance changes, escalating safety concerns, and deciding whether use should be adjusted or paused.
- Keep a record. Preserve information needed to review outputs, incidents, and corrective actions over time.
FDA describes drift detection, output monitoring, audit, and evaluation across multiple clinical sites as quality-assurance approaches. They can help identify changes and investigate variation; they do not guarantee safety or a financial return.
What can hospitals conclude about financial exposure?
Diagnostic errors are a recognized patient-safety and liability concern. A hospital malpractice-claims study found diagnosis-related paid claims were associated with greater adjusted risks of death and disability than other paid claim types. That is evidence about selected claims, not a measure of every diagnostic error or every hospital’s financial exposure.
Best Value
- All-in-One Health Record – Consolidate family history, allergies, surgeries, and medications in one trusted place. Have your complete story ready for any doctor visit or emergency.
- Daily Medication & Supplement Tracker – Log date, name, dosage, time, and notes each day, with space for up to 3 months of daily entries. Track adherence easily and discover what works best for your health.
- Doctor Visit & Lab Logs – Pre-fill your questions before appointments and record answers instantly. Keep all lab test results organized to monitor trends and share with your care team.
- Monthly Goals & Action Reviews – Set your top health priorities each month and plan specific actions. Reflect on your wins and improvements to build better habits over time.
- Sturdy Spiral Binding & Premium Paper – A5 format (5.5" × 8.3") with smooth 100gsm paper that resists bleed-through. The spiral binding lays flat for effortless daily writing.
The evidence presented here does not establish AI-attributable hospital costs, an AI-related malpractice total, or a link between AI misdiagnosis and hospital insolvency. Hospitals can make a more defensible assessment by tracking their own AI-influenced decisions, diagnostic outcomes, safety events, and costs, while distinguishing events involving AI from errors that occur without it.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
